CNBX Pharmaceuticals Inc (CNBX)
0.0112
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
CNBX Pharmaceuticals Total Assets (Quarterly): 0.1639M for Feb. 29, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.1639M |
| November 30, 2023 | 0.3874M |
| August 31, 2023 | 0.499M |
| May 31, 2023 | 0.662M |
| February 28, 2023 | 0.4621M |
| November 30, 2022 | 0.6095M |
| August 31, 2022 | 0.8112M |
| May 31, 2022 | 0.9657M |
| February 28, 2022 | 1.138M |
| November 30, 2021 | 2.120M |
| August 31, 2021 | 3.079M |
| May 31, 2021 | 3.802M |
| February 28, 2021 | 4.967M |
| November 30, 2020 | 1.698M |
| August 31, 2020 | 2.219M |
| May 31, 2020 | 5.528M |
| February 29, 2020 | 3.571M |
| November 30, 2019 | 6.462M |
| August 31, 2019 | 15.18M |
| May 31, 2019 | 19.77M |
| February 28, 2019 | 18.34M |
| November 30, 2018 | 9.483M |
| August 31, 2018 | 3.185M |
| May 31, 2018 | 3.160M |
| February 28, 2018 | 3.723M |
| Date | Value |
|---|---|
| November 30, 2017 | 3.062M |
| August 31, 2017 | 3.638M |
| May 31, 2017 | 3.463M |
| February 28, 2017 | 0.5916M |
| November 30, 2016 | 0.283M |
| August 31, 2016 | 0.0237M |
| May 31, 2016 | 0.0925M |
| February 29, 2016 | 0.0843M |
| November 30, 2015 | 0.2778M |
| August 31, 2015 | 0.0287M |
| May 31, 2015 | 4.440M |
| February 28, 2015 | 4.460M |
| November 30, 2014 | 4.498M |
| August 31, 2014 | 0.1142M |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.0011M |
| November 30, 2013 | 0.0314M |
| August 31, 2013 | 0.0728M |
| May 31, 2013 | 0.00 |
| February 28, 2013 | 0.00 |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.00 |
| May 31, 2012 | 0.00 |
| February 29, 2012 | 0.00 |
| November 30, 2011 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.1639M
Minimum
Feb 2024
19.77M
Maximum
May 2019
3.705M
Average
1.909M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.522M |
| Shareholders Equity (Quarterly) | -2.358M |
| Debt to Equity Ratio | -0.548 |
| Current Ratio | 0.065 |
| Net Debt Paydown Yield | 25.21% |